Hadassah University Hospital
Jerusalem 91240
4 studies enrolling now · 41 studies all time
What they study most
Amyotrophic Lateral Sclerosis, Becker Muscular Dystrophy, Bone Marrow Suppression, Chronic Pancreatitis, Crohn Disease, Crohn's Disease, Cystic Fibrosis, Diabetic Macular Edema, Diffuse Large B-cell Lymphoma, Dry Age-Related Macular Degeneration, Exocrine Pancreas Carcinoma, Familial Hypercholesterolemia
Studies at this site
- Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study — Recruiting now
- Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients — Recruiting now
- Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON) — Running, not enrolling
- Open-Label Extension of EDG-5506 in Participants With Becker Muscular Dystrophy — Enrolling by invitation
- A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL) — Running, not enrolling
- Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1) — Completed
- A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor) — Completed
- IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melanoma (IOB-013 / KN-D18) — Running, not enrolling
- A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma — Stopped early
- A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency — Completed
- Zimura in Participants With Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration — Completed
- Study of NG01 Cell Therapy in Secondary Progressive Multiple Sclerosis — Starting soon
- Performance of CHLOE Algorithm on the Prediction of Blastocyst Formation — Completed
- A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME) — Stopped early
- A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO) — Completed
- Comparing the Efficacy and Safety of Biosimilar Candidate Xlucane Versus Lucentis® in Patients With nAMD — Completed
- A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency — Completed
- Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma) — Completed
- Efficacy and Safety Study of Ozanimod in Ulcerative Colitis — Completed
- Open Label Extension Study of PREOS — Completed
- TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis — Completed
- An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy — Stopped early
- Phase 3 Study of Ataluren in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD) — Completed
- Study of Ataluren in Nonsense Mutation Cystic Fibrosis (ACT CF) — Completed
- Extension Study of Ataluren in Participants With Nonsense Mutation Cystic Fibrosis — Stopped early
- Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease — Stopped early
- Phase 1/2a DTA-H19 in Patients With Unresectable Pancreatic Cancer — Completed
- A Long-term Active Treatment Study of Mongersen (GED-0301) in Subjects With Crohn's Disease — Stopped early
- An Open Label Phase 2 Extension Study of Higher Dose Sialic Acid-Extended Release (SA-ER) Tablets and Sialic Acid-Immediate Release (SA-IR) Capsules in Patients With Glucosamine (UDP-N-acetyl)-2-Epimerase (GNE) Myopathy — Completed
- A Phase 2 Study to Evaluate the Dose and Pharmacodynamic Efficacy of Sialic Acid-Extended Release (SA-ER) Tablets in Patients With GNE Myopathy or Hereditary Inclusion Body Myopathy — Completed
- Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI) — Stopped early
- Safety and Efficacy Study of Metaglidasen in Type 2 Diabetes in Patients Suboptimally Controlled on Insulin — Completed
- Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid Leukemia — Completed
- Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count — Completed
- Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis — Completed
- PS-341 (VELCADE™) Versus High-Dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma — Completed
- A Study of PS-341 Given to Patients With Multiple Myeloma Who Experienced Progressive Disease After Receiving Dexamethasone in M34101-039 — Completed
- Oral OKT3 in Combination With Beta-D-Glucosylceramide — Status unconfirmed
- Study of XTL6865 in Patients With Chronic Hepatitis C Virus Infection — Status unconfirmed
- HepeX-B in Post Hepatic Allografts for Treatment of End Stage Liver Disease Due to Hepatitis B Infection — Stopped early
- Implitapide in Patients With Homozygous Familial Hypercholesterolemia (HoFH) on Maximal Concurrent Lipid-Lowering Therapy — Stopped early